← Eichor
Study identifier: NCT06647901 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Efficacy of ICG-based NIR Imaging in Intralesional Curettage of Giant Cell Tumors of Bone in Limbs: a Prospective, Single-center, Single-arm, Open Study

Condition: Giant Cell Tumor of Bone  ·  Sponsor: Tang Xiaodong

PhasePhase 1/Phase 2
Planned participants45
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersNo

About this study

ICG fluorescence imaging will be applied during the intralesional curettage of giant cell tumor of bone in the limbs. This study aims to preliminarily explore whether ICG fluorescent-guided curettage could find small residual tumors and reduce the recurrence rate of tumor.

This description comes directly from the study's public registry record.

Talk to the study team

Han Wang, MD  ·  +86 13520170664  ·  wh23333@126.com

Xiaodong Tang, MD  ·  +86 8832 6150  ·  tang15877@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

Peking University People's HospitalBeijing, Beijing Municipality, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06647901